2m 2m 2m 2m 2m 2m 2m
IMPACT BIO (IBO)
NYSE
$5.58+$0.15 (+2.84%)
Price as of Oct 02, 2026 4:22 PM EDT- $46.4MMarket Cap
- -33.25%1-Year Change
- BiotechnologyIndustry
IMPACT BIO (IBO)
$5.58+$0.15 (+2.84%)
IBO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.43 | ||
Change | -$0.17 (-3.04%) | ||
Open | $5.88 | ||
High | $5.88 | ||
Low | $5.43 | ||
Previous Close | $5.60 | ||
Volume | 8,991 | ||
30-Day Average Volume | 27,123 | ||
1-Week Change | -3.89% | ||
1-Month Change | -6.05% | ||
1-Year Change | -33.25% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 8.5M | ||
Total Assets | $16.7M | ||
Market Cap | $46.4M | ||
Enterprise Value | $83.7M | ||
Period: QTR TTM FY | |||
Revenue | $3,000.00 | ||
Net Income | -$699,000.00 | ||
Free Cash Flow | $470,000.00 | ||
EBIT | -$699,000.00 | ||
EBITDA | -$415,000.00 | ||
Net Working Capital | -$1.7M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -202 | ||
Enterprise Value/Revenue | 27,911 | ||
P/B | 4 | ||
P/E | -43 | ||
PEG | -1 | ||
Price/Free Cash Flow | 99 | ||
Price/Operating Cash Flow | 99 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12.62 | ||
Last Split Date | 09/23/2026 | ||
Earnings & Revenue